The Lancet, Early Online Publication, 15 February 2011
William Checkley aAsthma is a chronic respiratory disease that affects about 300 million individuals wordwide 1 —or 5% of the world's population—of whom about 46—78% are thought to have persistent symptoms that need long-term controller treatment. 2
Daily use of inhaled corticosteroids is the mainstay for persistent asthma. However, such drugs are absorbed by the lungs and have the potential for local and systemic side-effects, including reduced linear growth in children and adolescents. 3—8 Such drawbacks have led to ...
Weblink here
